Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
WuXi Biologics and Immune Pharmaceuticals announced a development and manufacturing agreement for the production of bertilimumab, Immune's first-in-class anti-eotaxin-1 monoclonal antibody.
read more
ProBioGen AG and Pionyr Immunotherapeutics have announced a second service and license agreement to develop novel antibody therapeutics.
read more
Moderna Therapeutics announced the opening of its state-of-the-art manufacturing facility in Norwood, Massachusetts.
read more
MassDevelopment has approved a 2 million dollar loan to Berkshire Sterile Manufacturing (BSM) for expansion of the company's sterile manufacturing facility located in Lee, MA.
read more
As part of our public health mission, the FDA monitors the pharmaceutical supply chain to support patient access to medically necessary drugs.
read more
West Pharmaceutical Services announced the official opening of its new Waterford, Ireland facility, a global center of excellence for West's advanced manufacturing network.
read more
Pfizer announced it will make a $465 million investment to build a sterile injectable pharmaceutical production facility in Portage, Michigan.
read more
Takara Bio announced the MPA has granted a manufacturing license for derivation and banking of human embryonic stem cells to be produced under GMP conditions within Takara Bio Europe's facility.
read more
Avid Bioservices announced the appointment of Daniel Hart as chief financial officer.
read more
Patients expect and deserve high-quality drugs – this means consistently safe and effective medicines, free of defects and contamination.
read more
Glenmark Pharmaceuticals and Harbour BioMed have entered into an exclusive license agreement for the Greater China territory to develop, manufacture and commercialize GBR 1302.
read more
Paragon Bioservices has announced two key leadership promotions.
read more
Thursday, August 16, 2018
Grifols has received approval from the FDA to relocate existing immunodiagnostic manufacturing operations to a new Consolidated Manufacturing Facility in Emeryville, California.
read more
GlaxoSmithKline’s Sligo plant will close the plant and lay off its 165 workers over the next three years.
read more
Thursday, August 23, 2018
bluebird bio and Gritstone Oncology announced a collaboration to research, develop and commercialize products for the treatment of cancer using cell therapy.
read more